ABBV vs. AVGO
ABBV (AbbVie Inc.) and AVGO (Broadcom Inc.) are both stocks. ABBV operates in Drug Manufacturers - General (Healthcare), while AVGO operates in Semiconductors (Technology). Over the past 10 years, ABBV returned 18.45%/yr vs 40.58%/yr for AVGO. At a 0.21 correlation, their price movements are largely independent.
Performance
ABBV vs. AVGO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABBV achieves a 1.08% return, which is significantly lower than AVGO's 11.68% return. Over the past 10 years, ABBV has underperformed AVGO with an annualized return of 18.45%, while AVGO has yielded a comparatively higher 40.58% annualized return.
ABBV
- 1D
- 1.02%
- 1M
- 10.83%
- YTD
- 1.08%
- 6M
- 2.16%
- 1Y
- 25.16%
- 3Y*
- 23.16%
- 5Y*
- 19.52%
- 10Y*
- 18.45%
AVGO
- 1D
- -7.92%
- 1M
- -9.33%
- YTD
- 11.68%
- 6M
- -0.76%
- 1Y
- 49.60%
- 3Y*
- 71.92%
- 5Y*
- 55.10%
- 10Y*
- 40.58%
ABBV vs. AVGO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 1.08% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
AVGO Broadcom Inc. | 11.68% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 44.88% | 29.05% | 2.18% | 48.19% |
Correlation
The correlation between ABBV and AVGO is -0.10, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013 | 0.21 |
The correlation between ABBV and AVGO shifts across timeframes, from -0.10 (1 year) to 0.21 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ABBV:
$403.11B
AVGO:
$1.88T
ABBV:
$2.05
AVGO:
$6.01
ABBV:
110.71
AVGO:
64.18
ABBV:
6.41
AVGO:
24.93
ABBV:
14.66
AVGO:
21.45
ABBV:
$62.82B
AVGO:
$75.47B
ABBV:
$46.15B
AVGO:
$50.53B
ABBV:
$17.96B
AVGO:
$41.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABBV vs. AVGO — Risk / Return Rank
ABBV
AVGO
ABBV vs. AVGO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABBV | AVGO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.05 | ||
| Sortino ratioReturn per unit of downside risk | -0.10 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.22 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 1.46 | 1.74 | -0.28 |
| Martin ratioReturn relative to average drawdown | 3.27 | 4.15 | -0.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ABBV | AVGO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.04 | 1.10 | -0.05 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.86 | 1.28 | -0.42 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.72 | 1.03 | -0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.75 | 1.08 | -0.34 |
Drawdowns
ABBV vs. AVGO - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum AVGO drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for ABBV and AVGO.
Loading charts...
Drawdown Indicators
| ABBV | AVGO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.09% | -48.30% | +3.21% |
Max Drawdown (1Y)Largest decline over 1 year | -17.32% | -28.67% | +11.35% |
Max Drawdown (3Y)Largest decline over 3 years | -20.74% | -41.15% | +20.41% |
Max Drawdown (5Y)Largest decline over 5 years | -21.92% | -41.15% | +19.23% |
Max Drawdown (10Y)Largest decline over 10 years | -45.09% | -48.30% | +3.21% |
Current DrawdownCurrent decline from peak | -4.81% | -19.90% | +15.09% |
Average DrawdownAverage peak-to-trough decline | -10.72% | -7.97% | -2.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.71% | 12.00% | -4.29% |
Volatility
ABBV vs. AVGO - Volatility Comparison
The current volatility for AbbVie Inc. (ABBV) is 6.15%, while Broadcom Inc. (AVGO) has a volatility of 20.03%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABBV | AVGO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.15% | 20.03% | -13.88% |
Volatility (6M)Calculated over the trailing 6-month period | 17.80% | 34.58% | -16.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.23% | 45.45% | -21.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.89% | 43.29% | -20.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.74% | 39.46% | -13.72% |
Dividends
ABBV vs. AVGO - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 2.97%, more than AVGO's 0.64% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.97% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
AVGO Broadcom Inc. | 0.64% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
Financials
ABBV vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABBV vs. AVGO - Profitability Comparison
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
AVGO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a gross profit of 14.92B and revenue of 22.19B. Therefore, the gross margin over that period was 67.2%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
AVGO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported an operating income of 10.87B and revenue of 22.19B, resulting in an operating margin of 49.0%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
AVGO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a net income of 9.31B and revenue of 22.19B, resulting in a net margin of 42.0%.
Frequently Asked Questions
ABBV and AVGO have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVGO has higher volatility (20.03%) compared to ABBV (6.15%). In terms of maximum drawdown, ABBV dropped -45.09% vs AVGO's -48.30%.
AVGO currently has the higher Sharpe Ratio (1.10 vs 1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABBV and AVGO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer